Evaluation of Topical Bevacizumab in Trabeculectomy
Not Applicable
- Conditions
- Glaucoma.Glaucoma (primary)(residual stage):chronic simple
- Registration Number
- IRCT2017041433424N1
- Lead Sponsor
- Vice chancellor for research, Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
intraocular pressure (IOP)>21 mmHg despite maximum tolerated medication and poor compliance leading to POAG.
Exclusion criteria : history of ocular surgery, congenital glaucoma, ocular inflammation, angle closure glaucoma, secondrty open angle glaucoma and soft tissue disease (Marfan syndrome, collagen vascular diseases etc.)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intra ocular pressure. Timepoint: before study and 1month and 6 months post operation. Method of measurement: goldman tenometer.
- Secondary Outcome Measures
Name Time Method Visual acuity. Timepoint: before study and 1month and 6 months post operation. Method of measurement: snelen chart.